Searched for
BIOCON BLOCK DEAL TODAY
Biocon shares: Active Pine may divest up to 1% equity worth Rs 638 crore via block dealActive Pine is likely to sell up to 1.66 crore Biocon shares, worth Rs 638 crore, through a block deal at Rs 385 per share. The development...- US stocks today: US stocks mixed at open as Gulf tensions send oil to over six-week highWall Street opened mixed on September 8 as renewed Middle East hostilities pushed oil prices to their highest level since late July. The Do...
- Sun Pharma gets ratings boost from Moody's, S&P over USD 11.75-bn Organon & Co acquisition bidRating agencies Moody's and S&P assigned investment-grade ratings to Sun Pharmaceutical Industries. This action follows Sun Pharma's propos...
- Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in BrazilBiocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis re...
- Biocon signs 10-year Brazil supply deal for Pertuzumab breast cancer drugIn a significant move, Biocon has secured a ten-year contract in Brazil for the distribution of Pertuzumab, made possible through its colla...
- Gland Pharma block deal: Fosun Pharma divests 99 lakh shares worth Rs 2,800 croreFosun Pharma sold a 6% stake in Gland Pharma for ₹2,800 crore via a block deal, reducing its holding to 45.77%. Major buyers included Kotak...
- Swiggy sees 4% equity change hands in block deals; shares gain 2.5%Swiggy shares rose 2.53% following block deals involving 4% equity. The company faces MSCI index removal on September 7 due to foreign owne...
- IEX shares rise 2% after electricity trading volume jumps 20% YoY to hit record high in AugustIEX shares rose on Friday after the exchange reported record monthly electricity trading volume of 13,938 MUs in August, up 20.2% year-on-y...
- Large trade alert! Gland Pharma shares fall 3% after 1.2 crore shares change hands in 2 block deals; promoter Fosun likely sellerGland Pharma shares fell 3% after 1.22 crore shares changed hands in two block deals worth nearly Rs 5,818 crore. Promoter Fosun Pharma Ind...
- Block deal alert! Gland Pharma shares fall 3% as 1.2 crore shares change hands in 2 block deals; promoter Fosun likely sellerGland Pharma shares fell after a significant block deal involving Fosun Pharma Industrial. The company's VSEZ facility received zero USFDA ...
- Gland Pharma shares: Promoter Fosun Pharma likely to divest 5% equity worth Rs 2,279 crore via block dealFosun Pharma plans to divest 5% equity in Gland Pharma through a Rs 2,279.5 crore block deal at Rs 2,763 per share. Gland Pharma reported a...
- Mirzapur: The Movie hit bumper prices across India. What fans are paying to watch Pankaj Tripathi, Ravi Kishan, Ali Fazal’s film in Delhi-NCR, Mumbai, Bengaluru and other citiesMirzapur: The Movie is all set to hit theaters on September 4, 2026, and anticipation is on the rise. Advance ticket sales are booming in m...
- AI startup Manus resumes independent operations after China blocks Meta’s $2 billion dealManus has now resumed independent operations after the regulatory intervention in the deal. The company informed users about data backups n...
- Blackstone-backed Epsilon Bidco may sell 26% stake in EPL in Rs 1,985-crore block dealBlackstone-backed Epsilon Bidco plans to sell its 26.4% stake in packaging firm EPL Ltd through a block deal valued at approximately Rs 1,9...
- Northern Arc Capital jumps 10% after Rs 335-crore block deal. Should you buy?Northern Arc Capital shares surged after 1.21 crore shares changed hands in a large block deal during the morning session. The stock hit an...
- Block, bulk deals hit 14-month high in August at Rs 80,000 croreBlock and bulk trades worth at least ₹80,000 crore were executed during the month - the highest since June 2025. Domestic mutual funds, ins...
- Lenskart Rs 1,857-crore block deal: Goldman Sachs, Morgan Stanley, ICICI Prudential, SBI MF among buyers as Alpha Wave exitsLenskart Solutions experienced institutional transactions totaling Rs 1,857 crore on August 28. Numerous domestic and global investors purc...
- Block deals test valuations; gig platforms quit welfare boardHappy Friday! Block deals are putting startups’ private valuations to the test. This and more in today’s ETtech Morning Dispatch.
- Startup block-deal rush puts private valuations to the cash testA rush of block deals in newly listed Indian startups is putting private-market valuations to the test. Early investors in Groww and Meesho...
- Biocon arm gets Japan nod for cancer drug pegfilgrastim biosimilarIn a significant advancement, Biocon Biologics has gained marketing approval for its pegfilgrastim biosimilar in Japan. This vital cancer s...
Load More
